Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?

[1]  A. Vaglio,et al.  Adult-onset IgA vasculitis (Henoch-Schönlein): update on therapy. , 2020, Presse medicale.

[2]  P. Canetta.  Toward a Clearer Picture of IgA Nephropathy in Spondyloarthritis , 2020, Kidney international reports.

[3]  Javier Martín,et al.  Influence of IL17A gene on the pathogenesis of immunoglobulin-A vasculitis. , 2020, Clinical and Experimental Rheumatology.

[4]  D. Roccatello,et al.  Rituximab in severe immunoglobulin-A vasculitis (Henoch-Schönlein) with aggressive nephritis. , 2020, Clinical and experimental rheumatology.

[5]  J. Hernández-Rodríguez,et al.  Rituximab treatment for IgA vasculitis: A systematic review. , 2020, Autoimmunity reviews.

[6]  A. Sarı,et al.  Damage assessment in adult IgA vasculitis. Cross-sectional results of a multicentre cohort. , 2020, Clinical and experimental rheumatology.

[7]  S. Özen,et al.  Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. , 2020, Rheumatology.

[8]  C. Crowson,et al.  Clinical Characteristics of Biopsy-Proven IgA Vasculitis in Children and Adults: A Retrospective Cohort Study. , 2019, Mayo Clinic proceedings.

[9]  S. Kamphuis,et al.  European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. , 2019, Rheumatology.

[10]  E. Świętochowska,et al.  Serum levels of selected cytokines [interleukin (IL)-17A, IL-18, IL-23] and chemokines (RANTES, IP10) in the acute phase of immunoglobulin A vasculitis in children , 2019, Rheumatology International.

[11]  B. Armağan,et al.  Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study , 2019, Rheumatology International.

[12]  C. Turesson,et al.  2018 Update of the EULAR recommendations for the management of large vessel vasculitis , 2019, Annals of the rheumatic diseases.

[13]  L. Oni,et al.  Childhood IgA Vasculitis (Henoch Schonlein Purpura)—Advances and Knowledge Gaps , 2019, Front. Pediatr..

[14]  K. John,et al.  Henoch-Schonlein purpura associated with HLA-B27 positive axial spondyloarthritis in a young man , 2019, BMJ Case Reports.

[15]  D. Kastner,et al.  Treatment Strategies for Deficiency of Adenosine Deaminase 2. , 2019, The New England journal of medicine.

[16]  C. Inderjeeth,et al.  Hospitalisation rates and characteristics for adult and childhood immunoglobulin A vasculitis in Western Australia , 2019, Internal medicine journal.

[17]  S. Özen,et al.  Comparing immunoglobulin A vasculitis (Henoch–Schönlein purpura) in children and adults: a single-centre study from Turkey , 2018, Scandinavian journal of rheumatology.

[18]  D. Roccatello,et al.  Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein) , 2018, Arthritis & rheumatology.

[19]  J. Sieper,et al.  What is the best treatment target in axial spondyloarthritis: tumour necrosis factor &agr;, interleukin 17, or both? , 2018, Rheumatology.

[20]  A. Jamin,et al.  New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura). , 2017, Autoimmunity reviews.

[21]  E. Thervet,et al.  Characteristics and Management of IgA Vasculitis (Henoch‐Schönlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey , 2017, Arthritis & rheumatology.

[22]  S. Ozen,et al.  P1_145 Two-year Results of a Prospective Vasculitis Cohort from Eastern Mediterranean: Demographic Characteristics and Distribution of the Vasculitides Frequencies , 2017 .

[23]  D. Roccatello,et al.  Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature , 2017, Immunologic research.

[24]  Jean A Donet,et al.  Henoch-Schönlein Purpura with Adalimumab Therapy for Ulcerative Colitis: A Case Report and Review of the Literature , 2016, Case reports in rheumatology.

[25]  P. Merkel,et al.  EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis , 2016, Annals of the rheumatic diseases.

[26]  Rohit Sharma.  Revised International Chapel Hill Consensus Conference nomenclature of vasculitides , 2016, Radiopaedia.org.

[27]  E. Thervet,et al.  IgA vasculitis (Henoch-Shönlein purpura) in adults: Diagnostic and therapeutic aspects. , 2015, Autoimmunity reviews.

[28]  Zhanju Liu,et al.  Severe Henoch-Schönlein purpura with infliximab for ulcerative colitis. , 2015, World journal of gastroenterology.

[29]  S. Özen,et al.  Studying cytokines of T helper cells in the kidney disease of IgA vasculitis (Henoch–Schönlein purpura) , 2015, Pediatric Nephrology.

[30]  O. Lambotte,et al.  Successful Outcome of a Corticodependent Henoch-Schönlein Purpura Adult with Rituximab , 2014, Case reports in medicine.

[31]  Yong-Beom Park,et al.  Differences in Clinical Manifestations and Outcomes between Adult and Child Patients with Henoch-Schönlein Purpura , 2014, Journal of Korean medical science.

[32]  M. González-Gay,et al.  Henoch-Schönlein Purpura in Northern Spain , 2014, Medicine.

[33]  Samuel H. Poon,et al.  Etanercept-Induced Henoch-Schönlein Purpura in a Patient With Ankylosing Spondylitis , 2013, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[34]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[35]  M. Paroli.  Clinical use of biologics in vasculitis syndromes , 2012, Biologics : targets & therapy.

[36]  M. Turman,et al.  Partial response to anakinra in life-threatening Henoch-Schönlein purpura: case report , 2011, Pediatric rheumatology online journal.

[37]  R. Panush.  Rituximab versus cyclophosphamide for ANCA-associated vasculitis , 2011 .

[38]  A. Bakkaloğlu,et al.  EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria , 2010, Annals of the rheumatic diseases.

[39]  D. Eleftheriou,et al.  Small vessel vasculitis , 2009, Pediatric Nephrology.

[40]  Yao-Hsu Yang,et al.  Clinical manifestations and outcomes of Henoch-Schönlein purpura: comparison between adults and children. , 2009, Pediatrics and neonatology.

[41]  G. Ramnath,et al.  Henoch–Schönlein purpura in children: an epidemiological study among Dutch paediatricians on incidence and diagnostic criteria , 2007, Annals of the rheumatic diseases.

[42]  A. Malaviya,et al.  Henoch-Schönlein's purpura in adults versus children/adolescents: A comparative study. , 2006, Clinical and experimental rheumatology.

[43]  S. M. Interna.  Internal and emergency medicine , 2006 .

[44]  M. González-Gay,et al.  Henoch-Schönlein purpura in children and adults: clinical differences in a defined population. , 2002, Seminars in arthritis and rheumatism.

[45]  E. Thervet,et al.  Henoch-Schönlein Purpura in adults: outcome and prognostic factors. , 2002, Journal of the American Society of Nephrology : JASN.

[46]  I. T. Ten Berge,et al.  What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? , 2001, Kidney international.

[47]  R. Monteiro,et al.  Elevation of serum IgA in spondyloarthropathies and IgA nephropathy and its pathogenic role. , 1999, Current opinion in rheumatology.

[48]  V. Rodríguez-Valverde,et al.  Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. , 1997, Arthritis and rheumatism.

[49]  A. Bakkaloğlu,et al.  The role of cytokines in Henoch Schonlein purpura. , 1997, Scandinavian journal of rheumatology.

[50]  G. Kaplan,et al.  Cutaneous vasculitis and IgA glomerulonephritis in ankylosing spondylitis. , 1993, Annals of the rheumatic diseases.

[51]  G. Hunder,et al.  The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. , 2010, Arthritis and rheumatism.

[52]  J. Rotés-Querol,et al.  Immunoglobulin A in the skin of patients with ankylosing spondylitis. , 1988, Annals of the rheumatic diseases.

[53]  M. Westedt,et al.  Relation of microscopic haematuria in ankylosing spondylitis to circulating IgA containing immune complexes. , 1988, Annals of the rheumatic diseases.

[54]  A. Ebringer,et al.  Association of inflammation with raised serum IgA in ankylosing spondylitis. , 1980, Annals of the rheumatic diseases.